Pegfilgrastim biosimilar (Reliance Life Sciences)

聚乙二醇非格司亭生物类似药（Reliance Life Sciences）

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePegfilgrastim biosimilar (Reliance Life Sciences)

Drug Alias Name培非拉司亭生物仿制药（Reliance Life Sciences）Pegfilgrastimum (Reliance Life Sciences)非格司亭生物仿制药（Reliance Life Sciences）聚乙二醇非格司亭生物仿制药（Reliance Life Sciences）乙二醇化非格司亭生物仿制药（Reliance Life Sciences） +[7]

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsNeutropenia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesReliance Life Sciences

China Registration ClassN/A

Develop Information

Active CompaniesReliance Life Sciences

Inactive CompaniesN/A

Active IndicationsNeutropenia

Inactive IndicationsN/A

Other Information

ATC CodeL03AA13